Treatment of ankylosing spondylitis with co‐amoxiclav
Sign Up to like & getrecommendations! Published in 2018 at "Clinical and Experimental Pharmacology and Physiology"
DOI: 10.1111/1440-1681.12952
Abstract: This article presents the efficacy of co‐amoxiclav in two patients with ankylosing spondylitis. Both patients were administered oral co‐amoxiclav for 7 days. The primary efficacy variable was the ankylosing spondylitis activity index. Secondary outcome measures… read more here.
Keywords: spondylitis amoxiclav; ankylosing spondylitis; treatment ankylosing; pharmacology ... See more keywords